Rapamycin attenuates ferroptotic stress and improves macrophage efferocytosis in experimental atherosclerosis.
Rapamycin attenuates ferroptotic and mitochondrial injury, restores macrophage efferocytosis, and reduces atherosclerotic plaque burden, supporting its therapeutic potential in experimental atherosclerosis.